glp-1 eczema GLP-1s in Dermatology GLP-1 Dermatologic Effects: What Clinicians

10.1016/j.metabol.2011.11.011

MAUD-obesity trial: Patients with obesity, no T2D, and markers of more severe AUD, comparing newer GLP-1 RAs to MAUD

Ibrahim NE, Gaggin HK, Turchin A et al (2019) Heart rate, beta-blocker use, and outcomes of heart failure with reduced ejection fraction

This is what it must feel like for someone who doesn't have to live with obesity, who has normal appetite regulation and is not thinking about food all the time." Mechanically, the result is the same negative energy balance that diet and exercise aim for

Retatrutide is still being evaluated in clinical trials, where researchers are studying its safety, effectiveness, and long-term outcomes